Lifeboat Foundation

Circa 2016 😗

Last month, Google’s AI division, DeepMind, announced that its computer had defeated Europe’s Go champion in five straight games. Go, a strategy game played on a 19×19 grid, is exponentially more difficult for a computer to master than chess—there are 20 possible moves to choose from at the start of a chess game compared to 361 moves in Go—and the announcement was lauded as another landmark moment in the evolution of artificial intelligence.

Or, at least, living neurons. His startup, Koniku, which just completed a stint at the biotech accelerator IndieBio, touts itself as “the first and only company on the planet building chips with biological neurons.” Rather than simply mimic brain function with chips, Agabi hopes to flip the script and borrow the actual material of human brains to create the chips.

Watch the Full Video at https://www.jove.com/v/55334/in-vivo-tracking-edema-developm…ideos-2022.

In Vivo Tracking of Edema Development and Microvascular Pathology in a Model of Experimental Cerebral Malaria Using Magnetic Resonance Imaging — a 2 minute Preview of the Experimental Protocol.

Continue reading “Cerebral Malaria Tracking” »

A child born in Australia today is expected to live until the age of 84.3, giving the nation the third-highest life expectancy in the world behind Monaco and Japan. The increase is due to its early covid-19 containment and high-performing healthcare system.

Elon Musk has been touting Tesla’s FSD Beta v11 for some time now, and it’s finally here. He says it will be ready for wide rollout before the end of 2022.

Amazon unveils its newest warehouse robotic arm that utilizes artificial intelligence, which proves a terrifying possibility for Amazon warehouse workers to be easily replaced. John Iadarola and Jessica Burbank break it down on The Damage Report.

Amazon’s new robot should strike fear into its hundreds of thousands of warehouse workers — https://www.businessinsider.com/amazon-released-warehouse-ro…022-11

Continue reading “Amazon Robot UNVEILED, Warehouse Worker Panic Stirs” »

For more information on pancreatic cancer, please visit https://cle.clinic/3rvBj1a.

Pancreatic cancer accounts for about 3% of all cancers in the United States and about 7% of all cancer deaths. Because it’s hard to detect early, it’s important to recognize any symptoms that occur.
Find out what to look for and when you should talk to your provider with this helpful video from Cleveland Clinic.

Continue reading “6 Warning Signs of Pancreatic Cancer” »

A vaccine (DCVax-L), trialed at King’s College Hospital and other centers around the world, using patients’ immune cells to target brain cancer can extend survival by many months or, in some cases, years, the final unblinded results from a phase 3 clinical trial has shown. The final results were published on Thursday, November 17 in JAMA Oncology.

This is the first time in 17 years that such significant outcomes have been achieved in a phase 3 trial for a systemic treatment in newly diagnosed glioblastoma, and the first time in 27 years that any treatment has been shown to extend survival in recurrent glioblastoma.

The vaccine is created for each patient individually by isolating specific immune cells, known as dendritic cells, from their blood. These cells are then primed with biomarkers from a sample of the patient’s tumor. When the vaccine containing the cells is injected back into the patient, it shares that information so that the body’s entire immune system recognizes and attacks the target.

To observe living cells through a microscope, a sample is usually squeezed onto a glass slide. It then lies there calmly and the cells are observable. The disadvantage is that this limits how the cells behave and it only produces two-dimensional images.

Researchers from UiT The Arctic University of Norway and the University Hospital of North Norway (UNN) have now developed what they are referring to as the next generation microscope. The new technology can take pictures of much larger samples than before, while living and working in a more natural environment.

Dogs cry tears of joy when reuniting with their owners.

Pet dogs produce a larger volume of tears when they are reunited with their owners than with acquaintances, possibly because of surging oxytocin levels—findings that could be the first evidence of emotional crying in nonhuman animals.